BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol 2014; 20(23): 7312-7324 [PMID: 24966602 DOI: 10.3748/wjg.v20.i23.7312] [Cited by in CrossRef: 202] [Cited by in F6Publishing: 178] [Article Influence: 25.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Hong R, Xie Y, Xu J. Melatonin Ameliorates Liver Fibrosis Induced by Carbon Tetrachloride in Rats via Inhibiting TGF-β1/Smad Signaling Pathway. CURR MED SCI 2018;38:236-44. [DOI: 10.1007/s11596-018-1871-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
2 Buonomo AR, Scotto R, Nappa S, Arcopinto M, Salzano A, Marra AM, D'Assante R, Zappulo E, Borgia G, Gentile I. The role of curcumin in liver diseases. Arch Med Sci 2019;15:1608-20. [PMID: 31749891 DOI: 10.5114/aoms.2018.73596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mohammed H, Varoni EM, Cochis A, Cordaro M, Gallenzi P, Patini R, Staderini E, Lajolo C, Rimondini L, Rocchetti V. Oral Dysbiosis in Pancreatic Cancer and Liver Cirrhosis: A Review of the Literature. Biomedicines 2018;6:E115. [PMID: 30544974 DOI: 10.3390/biomedicines6040115] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 7.8] [Reference Citation Analysis]
4 Lee SL, Chin TY, Lai CL, Wang WH. Sedum mexicanum Britt. Induces Apoptosis of Primary Rat Activated Hepatic Stellate Cells. Evid Based Complement Alternat Med 2015;2015:194373. [PMID: 26078767 DOI: 10.1155/2015/194373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
5 Chen D, Wen S, Wu Z, Gu Y, Chen Y, Chen X, Zhang Y, Lin B, Peng L, Zheng Y, Gao Z. Association between effective hepatic blood flow and the severity and prognosis of hepatitis B virus-related acute on chronic liver failure. Eur J Gastroenterol Hepatol 2021;32:246-54. [PMID: 32282547 DOI: 10.1097/MEG.0000000000001721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 O’Rourke JM, Sagar VM, Shah T, Shetty S. Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer. World J Gastroenterol 2018; 24(39): 4436-4447 [PMID: 30357021 DOI: 10.3748/wjg.v24.i39.4436] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 45] [Article Influence: 14.3] [Reference Citation Analysis]
7 Zaffaroni G, Okawa S, Morales-Ruiz M, Del Sol A. An integrative method to predict signalling perturbations for cellular transitions. Nucleic Acids Res 2019;47:e72. [PMID: 30949696 DOI: 10.1093/nar/gkz232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Yang Y, Min Z. Effect of long non‑coding RNA AK021443 on promoting hepatic fibrosis in vitro. Mol Med Rep 2021;23:196. [PMID: 33495828 DOI: 10.3892/mmr.2021.11835] [Reference Citation Analysis]
9 Sisto M, Ribatti D, Lisi S. Aquaporin water channels: New perspectives on the potential role in inflammation. Adv Protein Chem Struct Biol 2019;116:311-45. [PMID: 31036295 DOI: 10.1016/bs.apcsb.2018.11.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
10 Fu J, Wu B, Wu H, Lin F, Deng W. Accuracy of real-time shear wave elastography in staging hepatic fibrosis: a meta-analysis. BMC Med Imaging 2020;20:16. [PMID: 32046659 DOI: 10.1186/s12880-020-0414-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Kemp L, Clare KE, Brennan PN, Dillon JF. New horizons in hepatitis B and C in the older adult. Age Ageing 2019;48:32-7. [PMID: 30379991 DOI: 10.1093/ageing/afy170] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Gamboa CM, Wang Y, Xu H, Kalemba K, Wondisford FE, Sabaawy HE. Optimized 3D Culture of Hepatic Cells for Liver Organoid Metabolic Assays. Cells 2021;10:3280. [DOI: 10.3390/cells10123280] [Reference Citation Analysis]
13 Yokoyama T, Yagi Mendoza H, Tanaka T, Ii H, Takano R, Yaegaki K, Ishikawa H. Regulation of CCl4-induced liver cirrhosis by hepatically differentiated human dental pulp stem cells. Hum Cell 2019;32:125-40. [PMID: 30637566 DOI: 10.1007/s13577-018-00234-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
14 Sy BT, Hoan NX, Tong HV, Meyer CG, Toan NL, Song LH, Bock CT, Velavan TP. Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection. World J Gastroenterol 2018; 24(2): 248-256 [PMID: 29375210 DOI: 10.3748/wjg.v24.i2.248] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 de Souza VCA, Pereira TA, Teixeira VW, Carvalho H, de Castro MCAB, D’assunção CG, de Barros AF, Carvalho CL, de Lorena VMB, Costa VMA, Teixeira ÁAC, Figueiredo RCBQ, de Oliveira SA. Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress. World J Gastroenterol 2017; 23(28): 5146-5157 [PMID: 28811709 DOI: 10.3748/wjg.v23.i28.5146] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
16 Reza HA, Okabe R, Takebe T. Organoid transplant approaches for the liver. Transpl Int 2021;34:2031-45. [PMID: 34614263 DOI: 10.1111/tri.14128] [Reference Citation Analysis]
17 Rajapaksha IG, Angus PW, Herath CB. Current therapies and novel approaches for biliary diseases. World J Gastrointest Pathophysiol 2019; 10(1): 1-10 [PMID: 30622832 DOI: 10.4291/wjgp.v10.i1.1] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
18 Chokesuwattanaskul R, Thongprayoon C, Bathini T, O'Corragain OA, Sharma K, Preechawat S, Wijarnpreecha K, Kröner PT, Ungprasert P, Cheungpasitporn W. Epidemiology of atrial fibrillation in patients with cirrhosis and clinical significance: a meta-analysis. Eur J Gastroenterol Hepatol 2019;31:514-9. [PMID: 30451705 DOI: 10.1097/MEG.0000000000001315] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
19 Yang G, Zhan J, Yang Y, Yuan L, Wang P, Ho C, Li S. Inhibitory effects of oxyresveratrol on ERK and Smad1/2 phosphorylation and HSC activation in preventing carbon tetrachloride-induced rat liver fibrosis. Food Science and Human Wellness 2021;10:6-12. [DOI: 10.1016/j.fshw.2020.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Ghobadi Pour M, Mirazi N, Alaei H, Radahmadi M, Rajaei Z, Monsef Esfahani A. The effects of concurrent treatment of silymarin and lactulose on memory changes in cirrhotic male rats. Bioimpacts 2020;10:177-86. [PMID: 32793440 DOI: 10.34172/bi.2020.22] [Reference Citation Analysis]
21 Hu C, Zhao L, Tao J, Li L. Protective role of melatonin in early-stage and end-stage liver cirrhosis. J Cell Mol Med 2019;23:7151-62. [PMID: 31475778 DOI: 10.1111/jcmm.14634] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
22 Pradhan-Sundd T, Monga SP. Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology. Gene Expr 2019;19:69-87. [PMID: 30646969 DOI: 10.3727/105221619X15469715711907] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
23 Ou X, Mao S, Cao J, Ma Y, Ma G, Cheng A, Wang M, Zhu D, Chen S, Jia R, Liu M, Sun K, Yang Q, Wu Y, Chen X. The neglected avian hepatotropic virus induces acute and chronic hepatitis in ducks: an alternative model for hepatology. Oncotarget 2017;8:81838-51. [PMID: 29137226 DOI: 10.18632/oncotarget.19003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
24 Rahman MM, Shahab NB, Miah P, Rahaman MM, Kabir AU, Subhan N, Khan AA, Afroze M, Khan M, Ahmed KS, Hossain H, Haque MA, Alam MA. Polyphenol-rich leaf of Aphanamixis polystachya averts liver inflammation, fibrogenesis and oxidative stress in ovariectomized Long-Evans rats. Biomed Pharmacother 2021;138:111530. [PMID: 33773464 DOI: 10.1016/j.biopha.2021.111530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bezborodkina NN, Okovityi SV, Kudryavtsev BN. Postprandial Glycogen Content Is Increased in the Hepatocytes of Human and Rat Cirrhotic Liver. Cells 2021;10:976. [PMID: 33919385 DOI: 10.3390/cells10050976] [Reference Citation Analysis]
26 Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM. Ultrastructural characteristics of the respective forms of hepatic stellate cells in chronic hepatitis B as an example of high fibroblastic cell plasticity. The first assessment in children. Adv Med Sci 2018;63:127-33. [PMID: 29120853 DOI: 10.1016/j.advms.2017.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
27 Golonka RM, Cooper JK, Issa R, Devarasetty PP, Gokula V, Busken J, Zubcevic J, Hill J, Vijay-Kumar M, Menon B, Joe B. Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut-Liver Axis. Curr Hypertens Rep 2021;23:28. [PMID: 33961141 DOI: 10.1007/s11906-021-01142-9] [Reference Citation Analysis]
28 Sung S, Kim J, Jung Y. Liver-Derived Exosomes and Their Implications in Liver Pathobiology. Int J Mol Sci 2018;19:E3715. [PMID: 30469540 DOI: 10.3390/ijms19123715] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
29 Zarghamravanbakhsh P, Frenkel M, Poretsky L. Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD). Metabol Open 2021;12:100149. [PMID: 34870138 DOI: 10.1016/j.metop.2021.100149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
30 Poilil Surendran S, George Thomas R, Moon MJ, Jeong YY. Nanoparticles for the treatment of liver fibrosis. Int J Nanomedicine. 2017;12:6997-7006. [PMID: 29033567 DOI: 10.2147/ijn.s145951] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 7.4] [Reference Citation Analysis]
31 Akbari S, Arslan N, Senturk S, Erdal E. Next-Generation Liver Medicine Using Organoid Models. Front Cell Dev Biol 2019;7:345. [PMID: 31921856 DOI: 10.3389/fcell.2019.00345] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
32 Chang H, Meng HY, Liu SM, Wang Y, Yang XX, Lu F, Wang HY. Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach. Sci Rep 2017;7:11433. [PMID: 28900168 DOI: 10.1038/s41598-017-11759-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
33 Luo N, Li J, Wei Y, Lu J, Dong R. Hepatic Stellate Cell: A Double-Edged Sword in the Liver. Physiol Res 2021;70. [PMID: 34717063 DOI: 10.33549/physiolres.934755] [Reference Citation Analysis]
34 de Castro GLC, Bichara CDA, Santiago AM, de Brito WB, Pereira LMS, Moura TCF, da Silva Graça Amoras E, de Araújo MSM, da Silva Conde SRS, Queiroz MAF, Ishak R, Vallinoto ACR. Polymorphisms in the TGFB1 and FOXP3 genes are associated with the presence of antinuclear antibodies in chronic hepatitis C. Heliyon 2020;6:e04524. [PMID: 32743104 DOI: 10.1016/j.heliyon.2020.e04524] [Reference Citation Analysis]
35 Ohara M, Ohnishi S, Hosono H, Yamamoto K, Fu Q, Maehara O, Suda G, Sakamoto N. Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats. Front Pharmacol 2018;9:709. [PMID: 30057547 DOI: 10.3389/fphar.2018.00709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
36 Cooper M, Charest JL, Coppeta J. Design principles for dynamic microphysiological systems. Microfluidic Cell Culture Systems. Elsevier; 2019. pp. 1-29. [DOI: 10.1016/b978-0-12-813671-3.00001-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Nallagangula KS, Nagaraj SK, Venkataswamy L, Chandrappa M. Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression. Future Sci OA 2018;4:FSO250. [PMID: 29255622 DOI: 10.4155/fsoa-2017-0083] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
38 Sharma R, Reiter RJ, Ma Q. Melatonin: A hypothesis regarding its use to treat Wilson disease. Medical Hypotheses 2019;133:109408. [DOI: 10.1016/j.mehy.2019.109408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Khan M, Vaidyanath A, Suresh D, Vaishnav B, Kakrani AL, Patil S, Shiras A. Generation and characterization of three clones (NCCSi007A, NCCSi007B and NCCSi007C) of an integration free induced Pluripotent Stem Cell line from a patient with alcoholic liver cirrhosis of Indian ethnicity. Stem Cell Research 2020;42:101678. [DOI: 10.1016/j.scr.2019.101678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Zhang X, Yuan S, Zhang X, Zhang T, Meng C, Zhuang K, Dang S. ANGPTL4 regulates CD163 expression and Kuppfer cell polarization induced cirrhosis via TLR4/NF-κB pathway. Exp Cell Res 2021;405:112706. [PMID: 34146541 DOI: 10.1016/j.yexcr.2021.112706] [Reference Citation Analysis]
41 Guerra S, Mamede AC, Carvalho MJ, Laranjo M, Tralhão JG, Abrantes AM, Maia CJ, Botelho MF. Liver diseases: what is known so far about the therapy with human amniotic membrane? Cell Tissue Bank 2016;17:653-63. [PMID: 27550013 DOI: 10.1007/s10561-016-9579-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Li Y, Yan Y, Liu F, Wang L, Feng F, Xiao Y. Effects of calpain inhibitor on the apoptosis of hepatic stellate cells induced by calcium ionophore A23187. J Cell Biochem 2018. [PMID: 30191626 DOI: 10.1002/jcb.27478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Djiambou-Nganjeu H. Hepatic Encephalopathy in Liver Cirrhosis. J Transl Int Med. 2017;5:64-67. [PMID: 28680841 DOI: 10.1515/jtim-2017-0013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
44 Nallagangula KS, Lakshmaiah V, Muninarayana C, Deepa KV, Shashidhar KN. A proteomic approach of biomarker candidate discovery for alcoholic liver cirrhosis. J Circ Biomark 2018;7:1849454418788417. [PMID: 30034555 DOI: 10.1177/1849454418788417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 Lam P, Cheung F, Tan HY, Wang N, Yuen MF, Feng Y. Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities. Int J Mol Sci. 2016;17:465. [PMID: 27043533 DOI: 10.3390/ijms17040465] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 9.3] [Reference Citation Analysis]
46 Qiu R, Murata S, Oshiro K, Hatada Y, Taniguchi H. Transplantation of fetal liver tissue coated by ultra-purified alginate gel over liver improves hepatic function in the cirrhosis rat model. Sci Rep 2020;10:8231. [PMID: 32427847 DOI: 10.1038/s41598-020-65069-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
47 Liu T, Xu L, Wang C, Chen K, Xia Y, Li J, Li S, Wu L, Feng J, Xu S, Wang W, Lu X, Fan X, Mo W, Zhou Y, Zhao Y, Guo C. Alleviation of hepatic fibrosis and autophagy via inhibition of transforming growth factor-β1/Smads pathway through shikonin. J Gastroenterol Hepatol 2019;34:263-76. [PMID: 29864192 DOI: 10.1111/jgh.14299] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
48 Tadokoro T, Morishita A, Masaki T. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA. Int J Mol Sci 2021;22:8139. [PMID: 34360904 DOI: 10.3390/ijms22158139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Goto RL, Tablas MB, Prata GB, Espírito Santo SG, Fernandes AAH, Cogliati B, Barbisan LF, Romualdo GR. Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis. J Steroid Biochem Mol Biol 2022;215:106022. [PMID: 34774723 DOI: 10.1016/j.jsbmb.2021.106022] [Reference Citation Analysis]
50 García-Peñarrubia P, Ruiz-Alcaraz AJ, Ruiz-Ballester M, Ramírez-Pávez TN, Martínez-Esparza M. Recent insights into the characteristics and role of peritoneal macrophages from ascites of cirrhotic patients. World J Gastroenterol 2021; 27(41): 7014-7024 [PMID: 34887625 DOI: 10.3748/wjg.v27.i41.7014] [Reference Citation Analysis]
51 Fan Y, Yin X. Potential therapeutic targets and biological mechanisms of Centella asiatica on hepatic fibrosis: a study of network pharmacology. Ann Transl Med 2021;9:932. [PMID: 34350247 DOI: 10.21037/atm-21-2253] [Reference Citation Analysis]
52 Riaz F, Li D. Non-coding RNA Associated Competitive Endogenous RNA Regulatory Network: Novel Therapeutic Approach in Liver Fibrosis. Curr Gene Ther 2019;19:305-17. [PMID: 31696817 DOI: 10.2174/1566523219666191107113046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
53 Zhang Z, Yao Z, Chen Y, Qian L, Jiang S, Zhou J, Shao J, Chen A, Zhang F, Zheng S. Lipophagy and liver disease: New perspectives to better understanding and therapy. Biomed Pharmacother. 2018;97:339-348. [PMID: 29091883 DOI: 10.1016/j.biopha.2017.07.168] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
54 Hickman L, Tanner L, Christein J, Vickers S. Non-Hepatic Abdominal Surgery in Patients with Cirrhotic Liver Disease. J Gastrointest Surg 2019;23:634-42. [PMID: 30465191 DOI: 10.1007/s11605-018-3991-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
55 Wang J, Zhang Q, Cheng J, Chen L, Yao N, Sun G, Chu Y. Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road. Chin J Integr Med 2018;24:713-20. [DOI: 10.1007/s11655-018-3007-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Bender D, Hildt E. Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis. Int J Mol Sci 2019;20:E4659. [PMID: 31546975 DOI: 10.3390/ijms20184659] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
57 Wang TZ, Lin DD, Jin BX, Sun XY, Li N. Plasma microRNA: A novel non-invasive biomarker for HBV-associated liver fibrosis staging. Exp Ther Med. 2019;17:1919-1929. [PMID: 30783469 DOI: 10.3892/etm.2018.7117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
58 Ladegaard Grønkjær L, Hoppe Sehstedt T, Norlyk A, Vilstrup H. Overt Hepatic Encephalopathy Experienced by Individuals With Cirrhosis: A Qualitative Interview Study. Gastroenterol Nurs 2018;41:468-76. [PMID: 28759517 DOI: 10.1097/SGA.0000000000000286] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
59 Ramos-Lopez O, Martinez-Lopez E, Roman S, Fierro NA, Panduro A. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World J Gastroenterol 2015; 21(41): 11552-11566 [PMID: 26556986 DOI: 10.3748/wjg.v21.i41.11552] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
60 Chen Y, Fan Y, Guo DY, Xu B, Shi XY, Li JT, Duan LF. Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells. Biomed Pharmacother 2020;129:110413. [PMID: 32570119 DOI: 10.1016/j.biopha.2020.110413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
61 Fang H, Yu L, You D, Peng N, Guo W, Wang J, Zhang X. In vivo Therapeutic Effects and Mechanisms of Hydroxyasiaticoside Combined With Praziquantel in the Treatment of Schistosomiasis Induced Hepatic Fibrosis. Front Bioeng Biotechnol 2020;8:613784. [PMID: 33553120 DOI: 10.3389/fbioe.2020.613784] [Reference Citation Analysis]
62 Cao G, Zhu R, Jiang T, Tang D, Kwan HY, Su T. Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling. Phytomedicine 2019;63:153055. [PMID: 31377585 DOI: 10.1016/j.phymed.2019.153055] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
63 Hu C, Zhao L, Zhang L, Bao Q, Li L. Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury. Stem Cell Res Ther. 2020;11:377. [PMID: 32883343 DOI: 10.1186/s13287-020-01895-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
64 Smith-Cortinez N, van Eunen K, Heegsma J, Serna-Salas SA, Sydor S, Bechmann LP, Moshage H, Bakker BM, Faber KN. Simultaneous Induction of Glycolysis and Oxidative Phosphorylation during Activation of Hepatic Stellate Cells Reveals Novel Mitochondrial Targets to Treat Liver Fibrosis. Cells 2020;9:E2456. [PMID: 33187083 DOI: 10.3390/cells9112456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Bai R, Bai M, Zhao Z, Chen N, Yang Y, Tang Z. Alternation of supragingival microbiome in patients with cirrhosis of different Child-Pugh scores. Oral Dis 2020. [PMID: 33274586 DOI: 10.1111/odi.13743] [Reference Citation Analysis]
66 Ke B, Lee C. Cordyceps cicadae NTTU 868 mycelium prevents CCl 4 -induced hepatic fibrosis in BALB/c mice via inhibiting the expression of pro-inflammatory and pro-fibrotic cytokines. Journal of Functional Foods 2018;43:214-23. [DOI: 10.1016/j.jff.2018.02.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
67 Awan T, Babendreyer A, Wozniak J, Alvi AM, Sterzer V, Cook L, Bartsch JW, Liedtke C, Yildiz D, Ludwig A. Expression of the Metalloproteinase ADAM8 Is Upregulated in Liver Inflammation Models and Enhances Cytokine Release In Vitro. Mediators Inflamm 2021;2021:6665028. [PMID: 33814981 DOI: 10.1155/2021/6665028] [Reference Citation Analysis]
68 Saks K, Jensen KK, McLouth J, Hum J, Ahn J, Zaman A, Chang MF, Fung A, Schlansky B. Influence of spontaneous splenorenal shunts on clinical outcomes in decompensated cirrhosis and after liver transplantation. Hepatol Commun 2018;2:437-44. [PMID: 29619421 DOI: 10.1002/hep4.1157] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
69 Liu J, Yang P, Zuo G, He S, Tan W, Zhang X, Su C, Zhao L, Wei L, Chen Y, Ruan X, Chen Y. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress. Lipids Health Dis 2018;17:153. [PMID: 30016988 DOI: 10.1186/s12944-018-0790-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
70 Liu L, Zhou Y, Dai D, Xia H, Zhao K, Zhang J. Protective effects of Kangxian ruangan capsule against nonalcoholic fatty liver disease fibrosis in rats induced by MCD diet. Biomedicine & Pharmacotherapy 2018;108:424-34. [DOI: 10.1016/j.biopha.2018.06.134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
71 Muir AJ. Understanding the Complexities of Cirrhosis. Clinical Therapeutics 2015;37:1822-36. [DOI: 10.1016/j.clinthera.2015.05.507] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
72 Tan L, Meng Y, Zeng T, Wang Q, Long T, Wu S, Guan X, Fu H, Zheng W, Tian Y, Chen J, Yu J, Wu Y, Li H, Cao L. Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy. Br J Biomed Sci 2019;76:24-8. [PMID: 30392460 DOI: 10.1080/09674845.2018.1523673] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
73 Munday JS, Ridler A, Aberdein D, Thomson NA, Griffiths K. Chronic facial eczema in sheep: description of gross and histological changes in the liver and association with serum gamma-glutamyltransferase activity at the time of sporidesmin intoxication. N Z Vet J 2021;69:104-12. [PMID: 32981484 DOI: 10.1080/00480169.2020.1823904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Coscia C, Saxton E, Dickinson S. Postoperative Care of a Liver Transplant Recipient Using a Classification System: Type A (Stable) Versus Type B (Unstable). Crit Care Nurs Q 2016;39:252-66. [PMID: 27254641 DOI: 10.1097/CNQ.0000000000000119] [Reference Citation Analysis]
75 Xu SJ, Ye LP, Wang W, Chen YH, Dong J, Mao XL, Li SW. Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases. Stem Cells Int 2021;2021:5513309. [PMID: 34824587 DOI: 10.1155/2021/5513309] [Reference Citation Analysis]
76 Lee JW, Ko J, Ju C, Eltzschig HK. Hypoxia signaling in human diseases and therapeutic targets. Exp Mol Med. 2019;51:1-13. [PMID: 31221962 DOI: 10.1038/s12276-019-0235-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 63] [Article Influence: 15.0] [Reference Citation Analysis]
77 Nallagangula KS, Shashidhar KN, Lakshmaiah V, Muninarayana C. Cirrhosis of liver: Interference of serpins in quantification of SERPINA4 - A preliminary study. Pract Lab Med 2017;9:53-7. [PMID: 29159256 DOI: 10.1016/j.plabm.2017.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
78 Grønkjær LL, Andersen NG, Hansen LB, Sehstedt TH, Svensson NT, Sømod IE, Norlyk A, Bager P. Different views on hepatic encephalopathy: patients, relatives and nurses. Gastrointestinal Nursing 2016;14:S24-31. [DOI: 10.12968/gasn.2016.14.sup10.s24] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
79 Zheng L, Qin J, Sun L, Gui L, Zhang C, Huang Y, Deng W, Huang A, Sun D, Luo M. Intrahepatic upregulation of MRTF-A signaling contributes to increased hepatic vascular resistance in cirrhotic rats with portal hypertension. Clin Res Hepatol Gastroenterol 2017;41:303-10. [PMID: 28043789 DOI: 10.1016/j.clinre.2016.11.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
80 Ridha A, Al-Abboodi Y, Fasullo M. The Outcome of Thoracentesis versus Chest Tube Placement for Hepatic Hydrothorax in Patients with Cirrhosis: A Nationwide Analysis of the National Inpatient Sample. Gastroenterol Res Pract 2017;2017:5872068. [PMID: 29317865 DOI: 10.1155/2017/5872068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
81 Mohanty SK, Lobeck I, Donnelly B, Dupree P, Walther A, Mowery S, Coots A, Bondoc A, Sheridan RM, Poling HM, Temple H, McNeal M, Sestak K, Bansal R, Tiao G. Rotavirus Reassortant-Induced Murine Model of Liver Fibrosis Parallels Human Biliary Atresia. Hepatology 2020;71:1316-30. [PMID: 31442322 DOI: 10.1002/hep.30907] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
82 Ru L, Wang XM, Niu JQ. The miR-23-27-24 cluster: an emerging target in NAFLD pathogenesis. Acta Pharmacol Sin 2021. [PMID: 34893685 DOI: 10.1038/s41401-021-00819-w] [Reference Citation Analysis]
83 Herrera B, Addante A, Sánchez A. BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration. Int J Mol Sci 2017;19:E39. [PMID: 29295498 DOI: 10.3390/ijms19010039] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
84 Tang S, Huang Z, Jiang J, Gao J, Zhao C, Tai Y, Ma X, Zhang L, Ye Y, Gan C, Su W, Jia X, Liu R, Wu H, Tang C. Celecoxib ameliorates liver cirrhosis via reducing inflammation and oxidative stress along spleen-liver axis in rats. Life Sci 2021;272:119203. [PMID: 33577848 DOI: 10.1016/j.lfs.2021.119203] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Sánchez PS, Rigual MDM, Djouder N. Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis Development. Cancers (Basel) 2021;13:5045. [PMID: 34680192 DOI: 10.3390/cancers13205045] [Reference Citation Analysis]
86 Shoraka S, Mohebbi SR, Hosseini SM, Asadzadeh Aghdaei H, Zali MR. Identification of plasma lncRNA-ATB levels in hepatitis B virus-related cirrhosis and non-cirrhotic chronic hepatitis B patients. Virus Res 2021;303:198503. [PMID: 34331990 DOI: 10.1016/j.virusres.2021.198503] [Reference Citation Analysis]
87 Dibba P, Li AA, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A. The Role of Cannabinoids in the Setting of Cirrhosis. Medicines (Basel). 2018;5. [PMID: 29890719 DOI: 10.3390/medicines5020052] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
88 Fathy M, Khalifa EMMA, Fawzy MA. Modulation of inducible nitric oxide synthase pathway by eugenol and telmisartan in carbon tetrachloride-induced liver injury in rats. Life Sci 2019;216:207-14. [PMID: 30452970 DOI: 10.1016/j.lfs.2018.11.031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
89 Costas-rodríguez M, Anoshkina Y, Lauwens S, Van Vlierberghe H, Delanghe J, Vanhaecke F. Isotopic analysis of Cu in blood serum by multi-collector ICP-mass spectrometry: a new approach for the diagnosis and prognosis of liver cirrhosis? Metallomics 2015;7:491-8. [DOI: 10.1039/c4mt00319e] [Cited by in Crossref: 54] [Cited by in F6Publishing: 12] [Article Influence: 7.7] [Reference Citation Analysis]
90 Singh A, Pandey B. A New Intelligent Medical Decision Support System Based on Enhanced Hierarchical Clustering and Random Decision Forest for the Classification of Alcoholic Liver Damage, Primary Hepatoma, Liver Cirrhosis, and Cholelithiasis. J Healthc Eng 2018;2018:1469043. [PMID: 29599940 DOI: 10.1155/2018/1469043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
91 Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020;9:E875. [PMID: 32260126 DOI: 10.3390/cells9040875] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 24.5] [Reference Citation Analysis]
92 Jia Z, Gong Y, Pi Y, Liu X, Gao L, Kang L, Wang J, Yang F, Tang J, Lu W, Li Q, Zhang W, Yan Z, Yu L. pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis. Mol Pharm 2018;15:53-62. [PMID: 29148802 DOI: 10.1021/acs.molpharmaceut.7b00709] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
93 Chen L, Guo P, Li W, Fang F, Zhu W, Fan J, Wang F, Gao Y, Zhao Q, Wang Q, Xiao Y, Xing X, Li D, Shi T, Yu D, Aschner M, Zhang L, Chen W. Perturbation of Specific Signaling Pathways Is Involved in Initiation of Mouse Liver Fibrosis. Hepatology 2021;73:1551-69. [PMID: 32654205 DOI: 10.1002/hep.31457] [Reference Citation Analysis]
94 Cheng QN, Yang X, Wu JF, Ai WB, Ni YR. Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review). Mol Med Rep 2021;23:364. [PMID: 33760176 DOI: 10.3892/mmr.2021.12003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Feng J, Chen K, Xia Y, Wu L, Li J, Li S, Wang W, Lu X, Liu T, Guo C. Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways. Drug Des Devel Ther 2018;12:1837-53. [PMID: 29970958 DOI: 10.2147/DDDT.S162950] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 7.3] [Reference Citation Analysis]
96 Ezzeldin S, El-Wazir A, Enany S, Muhammad A, Johar D, Osama A, Ahmed E, Shikshaky H, Magdeldin S. Current Understanding of Human Metaproteome Association and Modulation. J Proteome Res 2019;18:3539-54. [PMID: 31262181 DOI: 10.1021/acs.jproteome.9b00301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
97 Luo L, Zhang G, Mao L, Wang P, Xi C, Shi G, Leavenworth JW. Group II muscarinic acetylcholine receptors attenuate hepatic injury via Nrf2/ARE pathway. Toxicol Appl Pharmacol 2020;395:114978. [PMID: 32234387 DOI: 10.1016/j.taap.2020.114978] [Reference Citation Analysis]
98 Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T. MicroRNA Interference in Hepatic Host-Pathogen Interactions. Int J Mol Sci 2021;22:3554. [PMID: 33808062 DOI: 10.3390/ijms22073554] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
99 Yoo HJ, Jung KJ, Kim M, Kim M, Kang M, Jee SH, Choi Y, Lee JH. Liver Cirrhosis Patients Who Had Normal Liver Function Before Liver Cirrhosis Development Have the Altered Metabolic Profiles Before the Disease Occurrence Compared to Healthy Controls. Front Physiol 2019;10:1421. [PMID: 31803070 DOI: 10.3389/fphys.2019.01421] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
100 Bellan M, Cittone MG, Tonello S, Rigamonti C, Castello LM, Gavelli F, Pirisi M, Sainaghi PP. Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis. Int J Mol Sci 2019;20:E5070. [PMID: 31614787 DOI: 10.3390/ijms20205070] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
101 Damiris K, Tafesh ZH, Pyrsopoulos N. Efficacy and safety of anti-hepatic fibrosis drugs. World J Gastroenterol 2020; 26(41): 6304-6321 [PMID: 33244194 DOI: 10.3748/wjg.v26.i41.6304] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
102 Lee SL, Hsu WH, Tu CM, Wang WH, Yang CY, Lee HK, Chin TY. The Effects of Freshwater Clam (Corbicula fluminea) Extract on Activated Hepatic Stellate Cells. Evid Based Complement Alternat Med 2021;2021:6065168. [PMID: 34804181 DOI: 10.1155/2021/6065168] [Reference Citation Analysis]
103 Li J, Zhang X, Chen L, Zhang Z, Zhang J, Wang W, Wu M, Shi B, Zhang X, Kozlowski M, Hu Y, Yuan Z. Circulating miR-210 and miR-22 combined with ALT predict the virological response to interferon-alpha therapy of CHB patients. Sci Rep. 2017;7:15658. [PMID: 29142236 DOI: 10.1038/s41598-017-15594-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
104 Bellan M, Castello LM, Pirisi M. Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review. J Clin Transl Hepatol 2018;6:317-25. [PMID: 30271745 DOI: 10.14218/JCTH.2018.00006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
105 Ignat SR, Dinescu S, Hermenean A, Costache M. Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development. Cells 2020;9:E461. [PMID: 32085494 DOI: 10.3390/cells9020461] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
106 Meng X, Wang H, Song X, Clifton AC, Xiao J. The potential role of senescence in limiting fibrosis caused by aging. J Cell Physiol 2020;235:4046-59. [PMID: 31637710 DOI: 10.1002/jcp.29313] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
107 Gudowska M, Gruszewska E, Panasiuk A, Cylwik B, Świderska M, Flisiak R, Szmitkowski M, Chrostek L. Selected Noninvasive Markers in Diagnosing Liver Diseases. Lab Med 2016;47:67-72. [PMID: 26715612 DOI: 10.1093/labmed/lmv015] [Reference Citation Analysis]
108 Omeish H, Hajjaj N, Abdulelah M, Bader H. You Only Find What You Are Looking for: Concurrent Alcoholic Liver Cirrhosis and Undiagnosed Wilson's Disease. Cureus 2021;13:e17117. [PMID: 34527496 DOI: 10.7759/cureus.17117] [Reference Citation Analysis]
109 Mir ZM, Djerboua M, Nanji S, Flemming JA, Groome PA. Predictors of Postoperative Liver Decompensation Events After Resection in Patients with Cirrhosis and Hepatocellular Carcinoma: A Population-Based Study. Ann Surg Oncol 2021. [PMID: 34549362 DOI: 10.1245/s10434-021-10801-9] [Reference Citation Analysis]
110 Furuya K, Zheng YW, Sako D, Iwasaki K, Zheng DX, Ge JY, Liu LP, Furuta T, Akimoto K, Yagi H, Hamada H, Isoda H, Oda T, Ohkohchi N. Enhanced hepatic differentiation in the subpopulation of human amniotic stem cells under 3D multicellular microenvironment. World J Stem Cells 2019; 11(9): 705-721 [PMID: 31616545 DOI: 10.4252/wjsc.v11.i9.705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
111 Wang Z, Chen N, Li Z, Xu G, Zhan X, Tang J, Xiao X, Bai Z. The Cytosolic DNA-Sensing cGAS-STING Pathway in Liver Diseases. Front Cell Dev Biol 2021;9:717610. [PMID: 34386500 DOI: 10.3389/fcell.2021.717610] [Reference Citation Analysis]
112 Triantos C, Kalafateli M, Aggeletopoulou I, Diamantopoulou G, Spantidea PI, Michalaki M, Vourli G, Konstantakis C, Assimakopoulos SF, Manolakopoulos S, Gogos C, Kyriazopoulou V, Mouzaki A, Thomopoulos K. Vitamin D-related immunomodulation in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2020;32:867-76. [PMID: 31789949 DOI: 10.1097/MEG.0000000000001597] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
113 Chang WJ, Song LJ, Yi T, Shen KT, Wang HS, Gao XD, Li M, Xu JM, Niu WX, Qin XY. Early activated hepatic stellate cell-derived molecules reverse acute hepatic injury. World J Gastroenterol 2015; 21(14): 4184-4194 [PMID: 25892868 DOI: 10.3748/wjg.v21.i14.4184] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
114 Cadney MD, Hiramatsu L, Thompson Z, Zhao M, Kay JC, Singleton JM, Albuquerque RL, Schmill MP, Saltzman W, Garland T Jr. Effects of early-life exposure to Western diet and voluntary exercise on adult activity levels, exercise physiology, and associated traits in selectively bred High Runner mice. Physiol Behav 2021;234:113389. [PMID: 33741375 DOI: 10.1016/j.physbeh.2021.113389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Acharya C, Sahingur SE, Bajaj JS. Microbiota, cirrhosis, and the emerging oral-gut-liver axis. JCI Insight. 2017;2:e94416. [PMID: 28978799 DOI: 10.1172/jci.insight.94416] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 14.4] [Reference Citation Analysis]
116 Ye L, Yu Y, Zhao Y. Icariin-induced miR-875-5p attenuates epithelial-mesenchymal transition by targeting hedgehog signaling in liver fibrosis. J Gastroenterol Hepatol 2020;35:482-91. [PMID: 31617598 DOI: 10.1111/jgh.14875] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
117 Park JS, Ma H, Roh YS. Ubiquitin pathways regulate the pathogenesis of chronic liver disease. Biochem Pharmacol 2021;193:114764. [PMID: 34529948 DOI: 10.1016/j.bcp.2021.114764] [Reference Citation Analysis]
118 Starokozhko V, Abza GB, Maessen HC, Merema MT, Kuper F, Groothuis GM. Viability, function and morphological integrity of precision-cut liver slices during prolonged incubation: Effects of culture medium. Toxicol In Vitro 2015;30:288-99. [PMID: 26514934 DOI: 10.1016/j.tiv.2015.10.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
119 Ni Y, Li JM, Liu MK, Zhang TT, Wang DP, Zhou WH, Hu LZ, Lv WL. Pathological process of liver sinusoidal endothelial cells in liver diseases. World J Gastroenterol 2017; 23(43): 7666-7677 [PMID: 29209108 DOI: 10.3748/wjg.v23.i43.7666] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
120 Erstad DJ, Farrar CT, Ghoshal S, Masia R, Ferreira DS, Chen YI, Choi JK, Wei L, Waghorn PA, Rotile NJ, Tu C, Graham-O'Regan KA, Sojoodi M, Li S, Li Y, Wang G, Corey KE, Or YS, Jiang L, Tanabe KK, Caravan P, Fuchs BC. Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonist. Hepatol Commun 2018;2:821-35. [PMID: 30027140 DOI: 10.1002/hep4.1193] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
121 Hedderich DM, Weiss K, Maintz D, Persigehl T. [Modern magnetic resonance imaging of the liver]. Radiologe 2015;55:1045-56. [PMID: 26628259 DOI: 10.1007/s00117-015-0031-4] [Reference Citation Analysis]
122 Pérez-cabeza de Vaca R, Domínguez-lópez M, Guerrero-celis N, Rodríguez-aguilera JR, Chagoya de Sánchez V. Inflammation is regulated by the adenosine derivative molecule, IFC-305, during reversion of cirrhosis in a CCl4 rat model. International Immunopharmacology 2018;54:12-23. [DOI: 10.1016/j.intimp.2017.10.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
123 Wang Y, Zhang H, Wang H. Progress of Interference of Traditional Chinese Medicine on Cirrhosis Treated with Bone Marrow Mesenchymal Stem Cells. Evid Based Complement Alternat Med 2021;2021:5569274. [PMID: 34055009 DOI: 10.1155/2021/5569274] [Reference Citation Analysis]
124 Istanbuly S, Matetic A, Mohamed MO, Panaich S, Velagapudi P, Elgendy IY, Paul TK, Alkhouli M, Mamas MA. Comparison of Outcomes of Patients With Versus Without Chronic Liver Disease Undergoing Percutaneous Coronary Intervention. Am J Cardiol 2021;156:32-8. [PMID: 34348842 DOI: 10.1016/j.amjcard.2021.06.044] [Reference Citation Analysis]
125 Llop E, Iruzubieta P, Perelló C, Fernández Carrillo C, Cabezas J, Escudero MD, González M, Hernández Conde M, Puchades L, Arias-Loste MT, Serra MÁ, Crespo J, Calleja JL. High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort. United European Gastroenterol J 2021. [PMID: 34077628 DOI: 10.1002/ueg2.12109] [Reference Citation Analysis]
126 Kweon M, Kim JY, Jun JH, Kim GJ. Research Trends in the Efficacy of Stem Cell Therapy for Hepatic Diseases Based on MicroRNA Profiling. Int J Mol Sci 2020;22:E239. [PMID: 33383629 DOI: 10.3390/ijms22010239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Fu LY, Wang SW, Hu MY, Jiang ZL, Shen LL, Zhou YP, Guo JM, Hu YR. Circular RNAs in liver diseases: Mechanisms and therapeutic targets. Life Sci 2021;264:118707. [PMID: 33144187 DOI: 10.1016/j.lfs.2020.118707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
128 Lin L, Chen G, Chen Z, Lu J, Zhu W, Zhong J, Peng F, Huang A. Prognostic value of tumor stromal collagen features in patients with hepatocellular carcinoma revealed by second-harmonic generation microscopy. Exp Mol Pathol 2020;116:104513. [PMID: 32735795 DOI: 10.1016/j.yexmp.2020.104513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
129 Olsavszky V, Sticht C, Schmid CD, Winkler M, Wohlfeil SA, Olsavszky A, Schledzewski K, Géraud C, Goerdt S, Leibing T, Koch PS. Exploring the transcriptomic network of multi-ligand scavenger receptor Stabilin-1- and Stabilin-2-deficient liver sinusoidal endothelial cells. Gene 2021;768:145284. [PMID: 33130055 DOI: 10.1016/j.gene.2020.145284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
130 Fu K, Wang C, Ma C, Zhou H, Li Y. The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity. Front Pharmacol 2021;12:771459. [PMID: 34803712 DOI: 10.3389/fphar.2021.771459] [Reference Citation Analysis]
131 Mu LY, Li SQ, Tang LX, Li R. Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis. Clinics (Sao Paulo) 2021;76:e2409. [PMID: 34133478 DOI: 10.6061/clinics/2021/e2409] [Reference Citation Analysis]
132 Odagiri N, Matsubara T, Sato-Matsubara M, Fujii H, Enomoto M, Kawada N. Anti-fibrotic treatments for chronic liver diseases: The present and the future. Clin Mol Hepatol 2021;27:413-24. [PMID: 33317250 DOI: 10.3350/cmh.2020.0187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Le J, Ji H, Zhou X, Wei X, Chen Y, Fu Y, Ma Y, Han Q, Sun Y, Gao Y, Wu H. Pharmacology, Toxicology, and Metabolism of Sennoside A, A Medicinal Plant-Derived Natural Compound. Front Pharmacol 2021;12:714586. [PMID: 34764866 DOI: 10.3389/fphar.2021.714586] [Reference Citation Analysis]
134 Sawalha K, Kadado AJ, Gupta K, Al-Akchar M, Battisha A, Abozenah M, Salerno C, Gupta M, Khan A, Islam AM. Outcomes of MitraClip Placement in Patients With Liver Cirrhosis. Cardiovasc Revasc Med 2021;29:50-3. [PMID: 32839129 DOI: 10.1016/j.carrev.2020.08.014] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
135 Zadorozhna M, Di Gioia S, Conese M, Mangieri D. Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment. Mol Biol Rep 2020;47:2279-88. [PMID: 32040707 DOI: 10.1007/s11033-020-05290-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
136 Shu M, Hu XR, Hung ZA, Huang DD, Zhang S. Effects of tanshinone IIA on fibrosis in a rat model of cirrhosis through heme oxygenase-1, inflammation, oxidative stress and apoptosis. Mol Med Rep. 2016;13:3036-3042. [PMID: 26936326 DOI: 10.3892/mmr.2016.4886] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
137 Chen VL, Chen Y, Du X, Handelman SK, Speliotes EK. Genetic variants that associate with cirrhosis have pleiotropic effects on human traits. Liver Int. 2020;40:405-415. [PMID: 31815349 DOI: 10.1111/liv.14321] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
138 Philips CA, Augustine P, Ahamed R, Rajesh S, George T, Valiathan GC, John SK. Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, 'Inside Any Deep Asking Is the Answering'. J Clin Transl Hepatol 2019;7:371-83. [PMID: 31915607 DOI: 10.14218/JCTH.2019.00034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
139 Wang S, Hu M, Qian Y, Jiang Z, Shen L, Fu L, Hu Y. CHI3L1 in the pathophysiology and diagnosis of liver diseases. Biomed Pharmacother 2020;131:110680. [PMID: 32861071 DOI: 10.1016/j.biopha.2020.110680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 D'souza S, Lau KCK, Coffin CS, Patel TR. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol 2020; 26(38): 5759-5783 [PMID: 33132633 DOI: 10.3748/wjg.v26.i38.5759] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
141 Iskandarov E, Kadaba Srinivasan P, Xin W, Bleilevens C, Afify M, Hamza A, Wei L, Hata K, Agayev B, Tolba R. Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection Model. Hepat Mon 2016;16:e36821. [PMID: 27799962 DOI: 10.5812/hepatmon.36821] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
142 Zhang Y, Ma LT, Li J, Qiao Y, Liu JY, Wang J, Ren QY, Hu JT, Zheng J. Anti-fibrotic Effects and Mechanism of Shengmai Injection () on Human Hepatic Stellate Cells LX-2. Chin J Integr Med 2019;25:197-202. [PMID: 30467694 DOI: 10.1007/s11655-018-2849-x] [Reference Citation Analysis]
143 Abdul-Hamid M, Ahmed RR, Moustafa N, Nady R. The antifibrogenic effect of etanercept on development of liver cirrhosis induced by thioacetamide in rats. Ultrastruct Pathol 2017;41:23-35. [PMID: 27982723 DOI: 10.1080/01913123.2016.1256361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
144 Lee PJ, Woo SJ, Jee JG, Sung SH, Kim HP. Bisdemethoxycurcumin Induces apoptosis in activated hepatic stellate cells via cannabinoid receptor 2. Molecules. 2015;20:1277-1292. [PMID: 25594342 DOI: 10.3390/molecules20011277] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
145 Zhang C, Han D. The value of color Doppler ultrasound in the diagnosis of upper gastrointestinal hemorrhage in patients with liver cirrhosis. Panminerva Med 2021;63:570-1. [PMID: 32875781 DOI: 10.23736/S0031-0808.20.04071-9] [Reference Citation Analysis]
146 Huang KC, Chuang MH, Lin ZS, Lin YC, Chen CH, Chang CL, Huang PC, Syu WS, Chiou TW, Hong ZH, Tsai YC, Harn HJ, Lin PC, Lin SZ. Transplantation with GXHPC1 for Liver Cirrhosis: Phase 1 Trial. Cell Transplant 2019;28:100S-11S. [PMID: 31722556 DOI: 10.1177/0963689719884885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
147 Rajapaksha IG, Gunarathne LS, Angus PW, Herath CB. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options. J Clin Med 2021;10:702. [PMID: 33670126 DOI: 10.3390/jcm10040702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
148 Wang XZ, Huang XY, Yao JG, Wang C, Xia Q, Long XD. Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1. Oncotarget 2018;9:27321-32. [PMID: 29937988 DOI: 10.18632/oncotarget.24535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
149 Chen S, Chen Y, Chen B, Cai YJ, Zou ZL, Wang JG, Lin Z, Wang XD, Fu LY, Hu YR. Plumbagin Ameliorates CCl 4 -Induced Hepatic Fibrosis in Rats via the Epidermal Growth Factor Receptor Signaling Pathway. Evid Based Complement Alternat Med. 2015;2015:645727. [PMID: 26550019 DOI: 10.1155/2015/645727] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
150 Maslennikov R, Pavlov C, Ivashkin V. Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis. Hepatol Int 2018;12:567-76. [PMID: 30284684 DOI: 10.1007/s12072-018-9898-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
151 Triantos C, Aggeletopoulou I, Kalafateli M, Spantidea PI, Vourli G, Diamantopoulou G, Tapratzi D, Michalaki M, Manolakopoulos S, Gogos C, Kyriazopoulou V, Mouzaki A, Thomopoulos K. Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis. Sci Rep 2018;8:14065. [PMID: 30218108 DOI: 10.1038/s41598-018-32482-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
152 Dourakis SP, Geladari E, Geladari C, Vallianou N. Cirrhotic Cardiomyopathy: The Interplay Between Liver and Cardiac Muscle. How Does the Cardiovascular System React When the Liver is Diseased? Curr Cardiol Rev 2021;17:78-84. [PMID: 31072296 DOI: 10.2174/1573403X15666190509084519] [Reference Citation Analysis]
153 Wang P, Lei S, Wang X, Xu W, Hu P, Chen F, Zhang X, Yin C, Xie W. MicroRNA-134 deactivates hepatic stellate cells by targeting TGF-β activated kinase 1-binding protein 1. Biochem Cell Biol 2019;97:505-12. [PMID: 30645141 DOI: 10.1139/bcb-2018-0211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
154 Sun J, Li Y, Sun X, Yu H, Liu Y. Dynamic Changes of the Aspartate Aminotransferase-to-Platelet Ratio and Transient Elastography in Predicting a Histologic Response in Patients With Chronic Hepatitis B After Entecavir Treatment. J Ultrasound Med 2019;38:1441-8. [PMID: 30244494 DOI: 10.1002/jum.14822] [Reference Citation Analysis]
155 Wu Z, Huang S, Zheng X, Gu S, Xu Q, Gong Y, Zhang J, Fu B, Tang L. Regulatory long non-coding RNAs of hepatic stellate cells in liver fibrosis (Review). Exp Ther Med 2021;21:351. [PMID: 33732324 DOI: 10.3892/etm.2021.9782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Zhang Y, Li R, Rong W, Han M, Cui C, Feng Z, Sun X, Jin S. Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4-induced hepatocirrhosis.Cell Death Dis. 2018;9:1186. [PMID: 30538216 DOI: 10.1038/s41419-018-1239-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
157 Sanchez-Antolín G, Almohalla-Alvarez C, Bueno P, Almansa R, Iglesias V, Rico L, Ortega A, Muñoz-Conejero E, García-Pajares F, Bermejo-Martin JF. Evidence of Active Pro-Fibrotic Response in Blood of Patients with Cirrhosis. PLoS One 2015;10:e0137128. [PMID: 26317806 DOI: 10.1371/journal.pone.0137128] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
158 Pomacu MM, Trașcă MD, Pădureanu V, Bugă AM, Andrei AM, Stănciulescu EC, Baniță IM, Rădulescu D, Pisoschi CG. Interrelation of inflammation and oxidative stress in liver cirrhosis. Exp Ther Med 2021;21:602. [PMID: 33936259 DOI: 10.3892/etm.2021.10034] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Lu MS, Lu HI, Chen TP, Chang CC, Yang TM, Chen MF. Survival of Patients with Lung Cancer in the Setting of Liver Cirrhosis: A Multicenter Propensity Score Matching Study. Cancer Manag Res 2021;13:4373-81. [PMID: 34103992 DOI: 10.2147/CMAR.S304980] [Reference Citation Analysis]
160 Zhang Y, Huang C, Nie Y, Liu Q, Xiao N, Liu L, Zhu X. Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis. Front Med (Lausanne) 2021;8:698502. [PMID: 34336902 DOI: 10.3389/fmed.2021.698502] [Reference Citation Analysis]
161 Zhou J, Wang W, Li Q. Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages. J Exp Clin Cancer Res 2021;40:73. [PMID: 33596985 DOI: 10.1186/s13046-021-01873-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
162 Romualdo GR, Grassi TF, Goto RL, Tablas MB, Bidinotto LT, Fernandes AAH, Cogliati B, Barbisan LF. An integrative analysis of chemically-induced cirrhosis-associated hepatocarcinogenesis: Histological, biochemical and molecular features. Toxicol Lett 2017;281:84-94. [PMID: 28943392 DOI: 10.1016/j.toxlet.2017.09.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
163 Sawalha K, Gupta K, Kadado AJ, Abozenah M, Battisha A, Salerno C, Khan A, Islam AM. In-hospital outcomes of transcatheter versus surgical mitral valve repair in patients with chronic liver disease. Int J Clin Pract 2021;:e14660. [PMID: 34322958 DOI: 10.1111/ijcp.14660] [Reference Citation Analysis]
164 Pinheiro D, Leirós L, Dáu JBT, Stumbo AC, Thole AA, Cortez EAC, Mandarim-de-Lacerda CA, Carvalho L, Carvalho SN. Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice. PLoS One 2017;12:e0187970. [PMID: 29176797 DOI: 10.1371/journal.pone.0187970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
165 Luo Y, Wu B, Wu Y, Peng L, Li Z, Zhu J, Su Z, Liu J, Li S, Chong Y. Atrial fibrillation increases inpatient and 4-year all-cause mortality in critically ill patients with liver cirrhosis. Ann Transl Med 2021;9:1239. [PMID: 34532376 DOI: 10.21037/atm-21-3111] [Reference Citation Analysis]
166 de Andrade KQ, Moura FA, dos Santos JM, de Araújo OR, de Farias Santos JC, Goulart MO. Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine. Int J Mol Sci 2015;16:30269-308. [PMID: 26694382 DOI: 10.3390/ijms161226225] [Cited by in Crossref: 115] [Cited by in F6Publishing: 97] [Article Influence: 16.4] [Reference Citation Analysis]
167 Mocarzel LO, Bicca J, Jarske L, Oliveira T, Lanzieri P, Gismondi R, Ribeiro ML. Cirrhotic Cardiomyopathy: Another Case of a Successful Approach to Treatment of Hepatorenal Syndrome. Case Rep Gastroenterol 2016;10:531-7. [PMID: 27843430 DOI: 10.1159/000448885] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
168 Moon H, Cho K, Shin S, Kim DY, Han KH, Ro SW. High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway. Int J Mol Sci. 2019;20. [PMID: 30700007 DOI: 10.3390/ijms20030581] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
169 Li RK, Ren XP, Yan FH, Qiang JW, Lin HM, Tao Wang, Zhao HF, Chen WB. Liver fibrosis detection and staging: a comparative study of T1ρ MR imaging and 2D real-time shear-wave elastography. Abdom Radiol (NY) 2018;43:1713-22. [PMID: 29198003 DOI: 10.1007/s00261-017-1381-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
170 Xiao X, Hu Q, Deng X, Shi K, Zhang W, Jiang Y, Ma X, Zeng J, Wang X. Old wine in new bottles: Kaempferol is a promising agent for treating the trilogy of liver diseases. Pharmacol Res 2021;175:106005. [PMID: 34843960 DOI: 10.1016/j.phrs.2021.106005] [Reference Citation Analysis]
171 Schwope RB, Katz M, Russell T, Reiter MJ, Lisanti CJ. The many faces of cirrhosis. Abdom Radiol (NY) 2020;45:3065-80. [PMID: 31190090 DOI: 10.1007/s00261-019-02095-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Ebrahimi H, Naderian M, Sohrabpour AA. New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article. Middle East J Dig Dis. 2018;10:133-148. [PMID: 30186577 DOI: 10.15171/mejdd.2018.103] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
173 Lee YH, Son JY, Kim KS, Park YJ, Kim HR, Park JH, Kim KB, Lee KY, Kang KW, Kim IS, Kacew S, Lee BM, Kim HS. Estrogen Deficiency Potentiates Thioacetamide-Induced Hepatic Fibrosis in Sprague-Dawley Rats. Int J Mol Sci 2019;20:E3709. [PMID: 31362375 DOI: 10.3390/ijms20153709] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
174 González-Reimers E, Quintero-Platt G, Martín-González C, Pérez-Hernández O, Romero-Acevedo L, Santolaria-Fernández F. Thrombin activation and liver inflammation in advanced hepatitis C virus infection. World J Gastroenterol 2016; 22(18): 4427-4437 [PMID: 27182154 DOI: 10.3748/wjg.v22.i18.4427] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
175 Ala M, Mohammad Jafari R, Hajiabbasi A, Dehpour AR. Aquaporins and diseases pathogenesis: From trivial to undeniable involvements, a disease-based point of view. J Cell Physiol 2021;236:6115-35. [PMID: 33559160 DOI: 10.1002/jcp.30318] [Reference Citation Analysis]
176 Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A, Kramvis A. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019;8:E1504. [PMID: 31771261 DOI: 10.3390/cells8121504] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
177 Xu T, Pan L, Li L, Hu S, Zhou H, Yang C, Yang J, Li H, Liu Y, Meng X, Li J. MicroRNA-708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88. J Cell Mol Med 2020;24:7127-40. [PMID: 32463570 DOI: 10.1111/jcmm.15119] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
178 Xu M, Chen L, Li J, Wu H, Xia Q, Kong X. Emerging roles of DJ-1 in liver diseases through regulation of oxidative stress and immune response. Liver Research 2018;2:87-91. [DOI: 10.1016/j.livres.2018.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
179 George J, Tsuchishima M, Tsutsumi M. Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent models. J Mol Med (Berl) 2020;98:1203-13. [PMID: 32666246 DOI: 10.1007/s00109-020-01950-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
180 Li Y, Yan Y, Liu F, Wang M, Feng F, Xiao Y. Effects of calcium Ionophore A23187 on the apoptosis of hepatic stellate cells stimulated by transforming growth factor-β1. Cell Mol Biol Lett 2018;23:1. [PMID: 29308067 DOI: 10.1186/s11658-017-0063-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
181 Strathearn LS, Stepanov AI, Font-Burgada J. Inflammation in Primary and Metastatic Liver Tumorigenesis-Under the Influence of Alcohol and High-Fat Diets. Nutrients 2020;12:E933. [PMID: 32230953 DOI: 10.3390/nu12040933] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
182 Rodríguez MJ, Sabaj M, Tolosa G, Herrera Vielma F, Zúñiga MJ, González DR, Zúñiga-Hernández J. Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation. Cells 2021;10:3406. [PMID: 34943914 DOI: 10.3390/cells10123406] [Reference Citation Analysis]
183 Chen CH, Chang CL, Chen KH, Cheng BC, Chen HH, Chiang JY, Sung PH, Yip HK. Level and Value of T Cell-derived Circulating Microparticles in Liver Cirrhosis Patients. In Vivo 2019;33:2265-72. [PMID: 31662566 DOI: 10.21873/invivo.11732] [Reference Citation Analysis]
184 Rahimi N, Hassanipour M, Allahabadi NS, Sabbaghziarani F, Yazdanparast M, Dehpour A. Cirrhosis induced by bile duct ligation alleviates acetic acid intestinal damages in rats: Involvements of nitrergic and opioidergic systems. Pharmacological Reports 2018;70:426-33. [DOI: 10.1016/j.pharep.2017.11.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
185 Tietze L, Kessler SM. The Good, the Bad, the Question-H19 in Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E1261. [PMID: 32429417 DOI: 10.3390/cancers12051261] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
186 Skurikhin EG, Zhukova MA, Pan ES, Ermakova NN, Pershina OV, Pakhomova AV, Putrova OD, Sandrikina LA, Krupin VA, Kogai LV, Rebrova TY, Afanas'ev SA, Dygai AM. Age-Related Features of the Response of the Liver and Stem Cells during Modeling of Liver Cirrhosis. Bull Exp Biol Med 2021;171:127-33. [PMID: 34046793 DOI: 10.1007/s10517-021-05184-6] [Reference Citation Analysis]
187 Wang N, Li X, Zhong Z, Qiu Y, Liu S, Wu H, Tang X, Chen C, Fu Y, Chen Q, Guo T, Li J, Zhang S, Zern MA, Ma K, Wang B, Ou Y, Gu W, Cao J, Chen H, Duan Y. 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway. J Nanobiotechnology 2021;19:437. [PMID: 34930304 DOI: 10.1186/s12951-021-01138-2] [Reference Citation Analysis]
188 Pérez-monter C, Escalona-nandez I, Estanes-hernández A, Noriega-lópez L, Torre-delgadillo A. Determinación de la microbiota intestinal en pacientes cirróticos de población mestizo-mexicana. Revista de Gastroenterología de México 2019;84:26-35. [DOI: 10.1016/j.rgmx.2018.02.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
189 Seo HY, Lee SH, Lee JH, Kang YN, Choi YK, Hwang JS, Park KG, Jang BK, Kim MK. Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway. Cells 2019;8:E1442. [PMID: 31739636 DOI: 10.3390/cells8111442] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
190 Cam I, Gencturk M, Lim N, Sharma S, Wong J, Yang M, Golzarian J, Flanagan S, Young S. Alcohol Recidivism Following Transjugular Intrahepatic Portosystemic Shunt Placement: Frequency and Predictive Factors. Cardiovasc Intervent Radiol 2021;44:758-65. [PMID: 33415418 DOI: 10.1007/s00270-020-02754-5] [Reference Citation Analysis]
191 Orbach SM, Ford AJ, Saverot SE, Rajagopalan P. Multi-cellular transitional organotypic models to investigate liver fibrosis. Acta Biomater 2018;82:79-92. [PMID: 30316024 DOI: 10.1016/j.actbio.2018.10.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
192 Günther C, Brevini T, Sampaziotis F, Neurath MF. What gastroenterologists and hepatologists should know about organoids in 2019. Dig Liver Dis 2019;51:753-60. [PMID: 30948332 DOI: 10.1016/j.dld.2019.02.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
193 de Oliveira da Silva B, Ramos LF, Moraes KCM. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis. Cell Biol Int 2017;41:946-59. [PMID: 28498509 DOI: 10.1002/cbin.10790] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
194 Liu H, Zhang S, Xu S, Koroleva M, Small EM, Jin ZG. Myofibroblast-specific YY1 promotes liver fibrosis. Biochem Biophys Res Commun 2019;514:913-8. [PMID: 31084931 DOI: 10.1016/j.bbrc.2019.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
195 Ali FE, Bakr AG, Abo-youssef AM, Azouz AA, Hemeida RA. Targeting Keap-1/Nrf-2 pathway and cytoglobin as a potential protective mechanism of diosmin and pentoxifylline against cholestatic liver cirrhosis. Life Sciences 2018;207:50-60. [DOI: 10.1016/j.lfs.2018.05.048] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
196 Heyens LJM, Busschots D, Koek GH, Robaeys G, Francque S. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front Med (Lausanne) 2021;8:615978. [PMID: 33937277 DOI: 10.3389/fmed.2021.615978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
197 Ghobadi Pour M, Mirazi N, Alaei H, Moradkhani S, Rajaei Z, Monsef Esfahani A. Effects of lactulose and silymarin on liver enzymes in cirrhotic rats. Can J Physiol Pharmacol 2017;95:522-9. [PMID: 28281782 DOI: 10.1139/cjpp-2016-0454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
198 Randhawa NK, Shastri T, Hassanin EH, Randhawa S. Initial Presentation of Cirrhosis Mimicking an Ischemic Stroke. Cureus 2021;13:e19474. [PMID: 34912615 DOI: 10.7759/cureus.19474] [Reference Citation Analysis]